We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Serious COVID-19 Patients Requiring Brain Imaging Face Higher Risk of Death, Finds Study

By MedImaging International staff writers
Posted on 24 Dec 2020
Illustration
Illustration
Hospitalized COVID-19 patients with neurological problems serious enough to warrant brain imaging have a higher risk of dying, according to a new study.

These findings by researchers at Montefiore Health System (New York City, NY, USA) and Albert Einstein College of Medicine (New York City, NY, USA) have the potential to identify and focus treatment efforts on individuals most at risk and could decrease COVID-19 deaths.

The study looked at data from 4,711 COVID-19 patients who were admitted to Montefiore during the six-week period between March 1, 2020 and April 16, 2020. Of those patients, 581 (12%) had neurological problems serious enough to warrant brain imaging. These individuals were compared with 1,743 non-neurological COVID-19 patients of similar age and disease severity who were admitted during the same period. Among people who underwent brain imaging, 55 were diagnosed with stroke and 258 people exhibited confusion or altered thinking ability. Individuals with stroke were twice as likely to die (49% mortality) compared with their matched controls (24% mortality) - a statistically significant difference. People with confusion had a 40% mortality rate compared with 33% for their matched controls - also statistically significant. More than half the stroke patients in the study did not have hypertension or other underlying risk factors for stroke.

“This study is the first to show that the presence of neurological symptoms, particularly stroke and confused or altered thinking, may indicate a more serious course of illness, even when pulmonary problems aren’t severe,” said David Altschul, M.D., chief of the division of neurovascular surgery at Einstein and Montefiore, and associate professor in the Leo M. Davidoff Department of Neurological Surgery and of radiology at Einstein. “Hospitals can use this knowledge to prioritize treatment and, hopefully, save more lives during this pandemic.”

Related Links:
Montefiore Health System
Albert Einstein College of Medicine


Post-Processing Imaging System
DynaCAD Prostate
Adjustable Mobile Barrier
M-458
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices
Ultrasonic Pocket Doppler
SD1

Channels

General/Advanced Imaging

view channel
Image: A multinational study reports that AI can quickly generate clinically acceptable radiotherapy plans across care settings (Photo courtesy of Adobe Stock)

AI Tool Automates Radiotherapy Planning for Cervical and Prostate Cancer

Cervical cancer causes most of its global mortality in low- and middle-income countries, where radiotherapy capacity and specialist staff are limited. Treatment planning is labor-intensive and can delay... Read more

Imaging IT

view channel
Image: Researchers develop a vision-language model trained on large-scale data to generate clinically relevant findings from chest computed tomography images through visual question answering (Ms. Maiko Nagao from Meijo University, Japan)

Interactive AI Tool Supports Explainable Lung Nodule Assessment

Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.